High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$143M
$143,448,355
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
McKechnie Duncan
• Officer • EVP, Chief Commercial Officer
10b5-1 SellΔOwn -13.9%
2026-03-04
$1,158,306Large
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP, Chief Commercial Officer
10b5-1 SellΔOwn -13.9%
|
2026-03-04 | $1,158,306Large | S | Form 4 |
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP and Chief Legal Officer
10b5-1 Sell
|
2026-03-02 | $442,396 | S | Form 4 |
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
CEO
10b5-1 Sell
|
2026-02-27 | $857,239 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Kewalramani Reshma
• CEO
10b5-1 Sell
2026-02-27
$2,974,479Large
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
CEO
10b5-1 Sell
|
2026-02-27 | $2,974,479Large | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Kewalramani Reshma
• CEO
10b5-1 SellΔOwn -12.8%
2026-02-27
$7,718,020Whale
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
CEO
10b5-1 SellΔOwn -12.8%
|
2026-02-27 | $7,718,020Whale | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Kewalramani Reshma
• CEO
10b5-1 Sell
2026-02-27
$1,729,166Large
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
CEO
10b5-1 Sell
|
2026-02-27 | $1,729,166Large | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Kewalramani Reshma
• CEO
10b5-1 Sell
2026-02-27
$1,243,091Large
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
CEO
10b5-1 Sell
|
2026-02-27 | $1,243,091Large | S | Form 4 |
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
CEO
10b5-1 Sell
|
2026-02-27 | $466,244 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Kewalramani Reshma
• CEO
10b5-1 Sell
2026-02-27
$1,336,722Large
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
CEO
10b5-1 Sell
|
2026-02-27 | $1,336,722Large | S | Form 4 |
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
CEO
10b5-1 Sell
|
2026-02-27 | $225,087 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Kewalramani Reshma
• CEO
10b5-1 Sell
2026-02-27
$1,600,549Large
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
CEO
10b5-1 Sell
|
2026-02-27 | $1,600,549Large | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Kewalramani Reshma
• CEO
10b5-1 Sell
2026-02-27
$1,222,696Large
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
CEO
10b5-1 Sell
|
2026-02-27 | $1,222,696Large | S | Form 4 |
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
CEO
10b5-1 Sell
|
2026-02-27 | $115,882 | S | Form 4 |
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
CEO
10b5-1 Sell
|
2026-02-27 | $57,780 | S | Form 4 |
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
CEO
10b5-1 Sell
|
2026-02-27 | $191,900 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Bozic Carmen
• Officer • EVP and CMO
10b5-1 Sell
2026-02-27
$1,118,642Large
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP and CMO
10b5-1 Sell
|
2026-02-27 | $1,118,642Large | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Ambrose Kristen
• Officer • SVP & Chief Accounting Officer
10b5-1 Sell
2026-02-26
$172,560
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • SVP & Chief Accounting Officer
10b5-1 Sell
|
2026-02-26 | $172,560 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Biller Jonathan
• Officer • EVP and Chief Legal Officer
10b5-1 Sell
2026-02-25
$459,601
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP and Chief Legal Officer
10b5-1 Sell
|
2026-02-25 | $459,601 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Bunnage Mark E.
• Officer • EVP, Chief Scientific Officer
10b5-1 Sell
2026-02-25
$301,537
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP, Chief Scientific Officer
10b5-1 Sell
|
2026-02-25 | $301,537 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
McKechnie Duncan
• Officer • EVP, Chief Commercial Officer
10b5-1 SellΔOwn -12.1%
2026-02-25
$1,178,490Large
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP, Chief Commercial Officer
10b5-1 SellΔOwn -12.1%
|
2026-02-25 | $1,178,490Large | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
McKechnie Duncan
• Officer • EVP, Chief Commercial Officer
10b5-1 SellΔOwn -11.1%
2026-02-25
$1,215,875Large
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP, Chief Commercial Officer
10b5-1 SellΔOwn -11.1%
|
2026-02-25 | $1,215,875Large | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Atkinson Edward Morrow III
• Officer • EVP, Chief Technical Ops. Off.
10b5-1 Sell
2026-02-25
$324,882
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP, Chief Technical Ops. Off.
10b5-1 Sell
|
2026-02-25 | $324,882 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Ambrose Kristen
• Officer • SVP & Chief Accounting Officer
10b5-1 Sell
2026-02-25
$108,456
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • SVP & Chief Accounting Officer
10b5-1 Sell
|
2026-02-25 | $108,456 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Tatsis Ourania
• Officer • EVP, Chief Reg. & Quality Off.
10b5-1 Sell
2026-02-25
$126,451
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP, Chief Reg. & Quality Off.
10b5-1 Sell
|
2026-02-25 | $126,451 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Sachdev Amit
• Officer • EVP Chief Patient & Ext Af Off
10b5-1 Sell
2026-02-25
$897,802
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP Chief Patient & Ext Af Off
10b5-1 Sell
|
2026-02-25 | $897,802 | S | Form 4 |
|
VRTX
M
VERTEX PHARMACEUTICALS INC / MA
Sachdev Amit
• Officer • EVP Chief Patient & Ext Af Off
Other
2026-02-19
$4,693,126Large
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP Chief Patient & Ext Af Off
Other
|
2026-02-19 | $4,693,126Large | M | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Sachdev Amit
• Officer • EVP Chief Patient & Ext Af Off
10b5-1 Sell
2026-02-19
$1,997,449Large
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP Chief Patient & Ext Af Off
10b5-1 Sell
|
2026-02-19 | $1,997,449Large | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Sachdev Amit
• Officer • EVP Chief Patient & Ext Af Off
10b5-1 SellΔOwn -15.6%
2026-02-19
$5,510,964Whale
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP Chief Patient & Ext Af Off
10b5-1 SellΔOwn -15.6%
|
2026-02-19 | $5,510,964Whale | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Sachdev Amit
• Officer • EVP Chief Patient & Ext Af Off
10b5-1 Sell
2026-02-19
$3,400,446Large
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP Chief Patient & Ext Af Off
10b5-1 Sell
|
2026-02-19 | $3,400,446Large | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Sachdev Amit
• Officer • EVP Chief Patient & Ext Af Off
10b5-1 SellΔOwn -19.3%
2026-02-19
$9,213,023Whale
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP Chief Patient & Ext Af Off
10b5-1 SellΔOwn -19.3%
|
2026-02-19 | $9,213,023Whale | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Sachdev Amit
• Officer • EVP Chief Patient & Ext Af Off
10b5-1 Sell
2026-02-19
$4,800,518Large
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP Chief Patient & Ext Af Off
10b5-1 Sell
|
2026-02-19 | $4,800,518Large | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Sachdev Amit
• Officer • EVP Chief Patient & Ext Af Off
10b5-1 Sell
2026-02-19
$860,798
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP Chief Patient & Ext Af Off
10b5-1 Sell
|
2026-02-19 | $860,798 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Sachdev Amit
• Officer • EVP Chief Patient & Ext Af Off
10b5-1 Sell
2026-02-19
$1,269,586Large
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP Chief Patient & Ext Af Off
10b5-1 Sell
|
2026-02-19 | $1,269,586Large | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Sachdev Amit
• Officer • EVP Chief Patient & Ext Af Off
10b5-1 Sell
2026-02-19
$426,797
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP Chief Patient & Ext Af Off
10b5-1 Sell
|
2026-02-19 | $426,797 | S | Form 4 |
|
VRTX
M
VERTEX PHARMACEUTICALS INC / MA
Sachdev Amit
• Officer • EVP Chief Patient & Ext Af Off
Other
2026-02-19
$3,652,628Large
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP Chief Patient & Ext Af Off
Other
|
2026-02-19 | $3,652,628Large | M | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Biller Jonathan
• Officer • EVP and Chief Legal Officer
10b5-1 Sell
2026-02-18
$589,258
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP and Chief Legal Officer
10b5-1 Sell
|
2026-02-18 | $589,258 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Tatsis Ourania
• Officer • EVP, Chief Reg. & Quality Off.
10b5-1 Sell
2026-02-18
$174,314
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP, Chief Reg. & Quality Off.
10b5-1 Sell
|
2026-02-18 | $174,314 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Ambrose Kristen
• Officer • SVP & Chief Accounting Officer
10b5-1 Sell
2026-02-18
$302,208
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • SVP & Chief Accounting Officer
10b5-1 Sell
|
2026-02-18 | $302,208 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Atkinson Edward Morrow III
• Officer • EVP, Chief Technical Ops. Off.
10b5-1 Sell
2026-02-18
$386,997
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP, Chief Technical Ops. Off.
10b5-1 Sell
|
2026-02-18 | $386,997 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Bunnage Mark E.
• Officer • EVP, Chief Scientific Officer
10b5-1 SellΔOwn -12.2%
2026-02-18
$559,890
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP, Chief Scientific Officer
10b5-1 SellΔOwn -12.2%
|
2026-02-18 | $559,890 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Biller Jonathan
• Officer • EVP and Chief Legal Officer
10b5-1 SellΔOwn -12.7%
2026-02-17
$1,211,903Large
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP and Chief Legal Officer
10b5-1 SellΔOwn -12.7%
|
2026-02-17 | $1,211,903Large | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Ambrose Kristen
• Officer • SVP & Chief Accounting Officer
10b5-1 SellΔOwn -15.7%
2026-02-17
$762,089
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • SVP & Chief Accounting Officer
10b5-1 SellΔOwn -15.7%
|
2026-02-17 | $762,089 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Bunnage Mark E.
• Officer • EVP, Chief Scientific Officer
10b5-1 SellΔOwn -20.1%
2026-02-17
$1,192,814Large
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP, Chief Scientific Officer
10b5-1 SellΔOwn -20.1%
|
2026-02-17 | $1,192,814Large | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Atkinson Edward Morrow III
• Officer • EVP, Chief Technical Ops. Off.
10b5-1 Sell
2026-02-17
$994,093
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP, Chief Technical Ops. Off.
10b5-1 Sell
|
2026-02-17 | $994,093 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Tatsis Ourania
• Officer • EVP, Chief Reg. & Quality Off.
10b5-1 Sell
2026-02-17
$298,081
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP, Chief Reg. & Quality Off.
10b5-1 Sell
|
2026-02-17 | $298,081 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Bhatia Sangeeta N.
• Director
10b5-1 Sell
2026-02-13
$133,000
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Director
10b5-1 Sell
|
2026-02-13 | $133,000 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Tatsis Ourania
• Officer • EVP, Chief Reg. & Quality Off.
10b5-1 Sell
2026-02-13
$749,985
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP, Chief Reg. & Quality Off.
10b5-1 Sell
|
2026-02-13 | $749,985 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Biller Jonathan
• Officer • EVP and Chief Legal Officer
10b5-1 Sell
2026-02-13
$493,012
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP and Chief Legal Officer
10b5-1 Sell
|
2026-02-13 | $493,012 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Ambrose Kristen
• Officer • SVP & Chief Accounting Officer
10b5-1 SellΔOwn -12.0%
2026-02-11
$633,552
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • SVP & Chief Accounting Officer
10b5-1 SellΔOwn -12.0%
|
2026-02-11 | $633,552 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Atkinson Edward Morrow III
• Officer • EVP, Chief Technical Ops. Off.
10b5-1 Sell
2026-02-11
$806,213
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP, Chief Technical Ops. Off.
10b5-1 Sell
|
2026-02-11 | $806,213 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Bunnage Mark E.
• Officer • EVP, Chief Scientific Officer
10b5-1 SellΔOwn -13.5%
2026-02-11
$930,529
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP, Chief Scientific Officer
10b5-1 SellΔOwn -13.5%
|
2026-02-11 | $930,529 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Tatsis Ourania
• Officer • EVP, Chief Reg. & Quality Off.
10b5-1 Sell
2026-02-11
$214,560
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP, Chief Reg. & Quality Off.
10b5-1 Sell
|
2026-02-11 | $214,560 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Biller Jonathan
• Officer • EVP and Chief Legal Officer
10b5-1 Sell
2026-02-11
$886,328
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP and Chief Legal Officer
10b5-1 Sell
|
2026-02-11 | $886,328 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Tatsis Ourania
• Officer • EVP, Chief Reg. & Quality Off.
10b5-1 Sell
2026-01-07
$2,137,455Large
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP, Chief Reg. & Quality Off.
10b5-1 Sell
|
2026-01-07 | $2,137,455Large | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
WAGNER CHARLES F JR
• Officer • EVP, CO & FO
10b5-1 SellΔOwn -20.2%
2026-01-06
$4,394,252Large
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP, CO & FO
10b5-1 SellΔOwn -20.2%
|
2026-01-06 | $4,394,252Large | S | Form 4 |
|
VRTX
M
VERTEX PHARMACEUTICALS INC / MA
WAGNER CHARLES F JR
• Officer • EVP, CO & FO
Equity Compensation
2026-01-06
$0
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP, CO & FO
Equity Compensation
|
2026-01-06 | $0 | M | Form 4 |
|
VRTX
M
VERTEX PHARMACEUTICALS INC / MA
WAGNER CHARLES F JR
• Officer • EVP, CO & FO
Other
2026-01-06
$1,805,170Large
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP, CO & FO
Other
|
2026-01-06 | $1,805,170Large | M | Form 4 |
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Chair
Other
|
2025-12-04 | $91 | M | Form 4 |
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Chair
Equity Compensation
|
2025-12-04 | $0 | M | Form 4 |
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Chair
Other
|
2025-12-03 | $5,518,332Whale | M | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
WAGNER CHARLES F JR
• Officer • EVP, CO & FO
10b5-1 SellΔOwn -13.5%
2025-12-03
$3,157,000Large
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP, CO & FO
10b5-1 SellΔOwn -13.5%
|
2025-12-03 | $3,157,000Large | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
LEIDEN JEFFREY M
• Chair
10b5-1 SellΔOwn -10.0%
2025-12-03
$2,621,021Large
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Chair
10b5-1 SellΔOwn -10.0%
|
2025-12-03 | $2,621,021Large | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
LEIDEN JEFFREY M
• Chair
10b5-1 Sell
2025-12-03
$2,645,059Large
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Chair
10b5-1 Sell
|
2025-12-03 | $2,645,059Large | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
LEIDEN JEFFREY M
• Chair
10b5-1 Sell
2025-12-03
$1,041,170Large
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Chair
10b5-1 Sell
|
2025-12-03 | $1,041,170Large | S | Form 4 |
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Chair
10b5-1 Sell
|
2025-12-03 | $515,002 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
LEIDEN JEFFREY M
• Chair
10b5-1 SellΔOwn -10.5%
2025-12-03
$3,519,478Large
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Chair
10b5-1 SellΔOwn -10.5%
|
2025-12-03 | $3,519,478Large | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
LEIDEN JEFFREY M
• Chair
10b5-1 Sell
2025-12-03
$1,933,855Large
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Chair
10b5-1 Sell
|
2025-12-03 | $1,933,855Large | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
LEIDEN JEFFREY M
• Chair
10b5-1 Sell
2025-12-03
$1,094,285Large
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Chair
10b5-1 Sell
|
2025-12-03 | $1,094,285Large | S | Form 4 |
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Chair
10b5-1 Sell
|
2025-12-03 | $582,463 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
LEIDEN JEFFREY M
• Chair
10b5-1 Sell
2025-12-03
$1,968,148Large
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Chair
10b5-1 Sell
|
2025-12-03 | $1,968,148Large | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
WAGNER CHARLES F JR
• Officer • EVP, CO & FO
10b5-1 SellΔOwn -15.7%
2025-12-03
$3,227,000Large
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP, CO & FO
10b5-1 SellΔOwn -15.7%
|
2025-12-03 | $3,227,000Large | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Tatsis Ourania
• Officer • EVP, Chief Reg. & Quality Off.
10b5-1 Sell
2025-12-03
$2,024,955Large
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP, Chief Reg. & Quality Off.
10b5-1 Sell
|
2025-12-03 | $2,024,955Large | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Biller Jonathan
• Officer • EVP and Chief Legal Officer
10b5-1 Sell
2025-12-03
$155,803
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP and Chief Legal Officer
10b5-1 Sell
|
2025-12-03 | $155,803 | S | Form 4 |
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Chair
Equity Compensation
|
2025-12-03 | $0 | M | Form 4 |
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Chair
10b5-1 Sell
|
2025-12-03 | $942,305 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
LEIDEN JEFFREY M
• Chair
10b5-1 SellΔOwn -28.4%
2025-12-03
$4,696,602Large
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Chair
10b5-1 SellΔOwn -28.4%
|
2025-12-03 | $4,696,602Large | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
LEIDEN JEFFREY M
• Chair
10b5-1 SellΔOwn -30.1%
2025-12-03
$7,090,948Whale
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Chair
10b5-1 SellΔOwn -30.1%
|
2025-12-03 | $7,090,948Whale | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Atkinson Edward Morrow III
• Officer • EVP, Chief Technical Ops. Off.
10b5-1 SellΔOwn -12.9%
2025-11-17
$1,086,450Large
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP, Chief Technical Ops. Off.
10b5-1 SellΔOwn -12.9%
|
2025-11-17 | $1,086,450Large | S | Form 4 |
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Chair
Other
|
2025-11-14 | $1,259,677Large | M | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
LEIDEN JEFFREY M
• Chair
10b5-1 SellΔOwn -41.5%
2025-11-14
$14,192,630MEGA
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Chair
10b5-1 SellΔOwn -41.5%
|
2025-11-14 | $14,192,630MEGA | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
LEIDEN JEFFREY M
• Chair
10b5-1 SellΔOwn -47.0%
2025-11-14
$9,413,996Whale
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Chair
10b5-1 SellΔOwn -47.0%
|
2025-11-14 | $9,413,996Whale | S | Form 4 |
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Chair
Other
|
2025-11-14 | $3,440,814Large | M | Form 4 |
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Chair
10b5-1 Sell
|
2025-11-14 | $17,680 | S | Form 4 |
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Chair
Other
|
2025-11-13 | $1,792,592Large | M | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
LEIDEN JEFFREY M
• Chair
10b5-1 SellΔOwn -42.4%
2025-11-13
$8,156,396Whale
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Chair
10b5-1 SellΔOwn -42.4%
|
2025-11-13 | $8,156,396Whale | S | Form 4 |
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Chair
10b5-1 Sell
|
2025-11-13 | $511,618 | S | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
Biller Jonathan
• Officer • EVP and Chief Legal Officer
10b5-1 Sell
2025-10-02
$280,522
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Officer • EVP and Chief Legal Officer
10b5-1 Sell
|
2025-10-02 | $280,522 | S | Form 4 |